Veterans

For more information concerning work and views related to Veterans' issues, please contact our office.
More on Veterans
Congress is on track to approve legislation that would mark a significant advance in U.S. policy toward psychedelics.
Tucked into the National Defense Authorization Act of 2024 is a provision to fund clinical trials using psychedelic substances to treat active duty members of the military.
Bipartisan and bicameral congressional lawmakers have reached an agreement on a large-scale defense bill that contains a House GOP-led section to fund studies into the therapeutic use of psychedelics such as psilocybin and MDMA for military service members.
Rep. Morgan Luttrell (R-TX) and thirteen Republican colleagues sent a letter to Department of Veterans Affairs (VA) Secretary Denis McDonough on Thursday demanding action against a VA employee who mocked Israel for wanting back hostages held by Palestinian terrorist organization Hamas, Breitbart News has exclusively learned.
WASHINGTON – Congressman Morgan Luttrell (R-TX) led 13 of his colleagues in a letter to Department of Veterans Affairs Secretary Dennis McDonough following disturbing antisemitic comments posted online by Shakeba Morrad, a United States Attorney at the Office of General Counsel for the United States Department of Veterans Affairs.
WASHINGTON – There are 72,000 hearings for veteran claims now pending before the Board of Veterans’ Appeals, an official for a federal watchdog agency told House lawmakers on Wednesday.
By Rick Perry, Marcus Luttrell, Morgan Luttrell & Dakota Meyer
As the opioid epidemic continues to grip our nation, claiming lives, destroying families, and burdening communities, it is imperative that we explore every viable solution. Among these potential solutions is a powerful, natural, non-addictive substance known as ibogaine.
More than twice as many U.S. service members may have been injured in recent attacks in Iraq and Syria than the Pentagon previously disclosed, U.S. defense officials said on Monday.
Experts and advocates—including a Department of Veterans Affairs (VA) official and a former director of the Centers for Disease Control and Prevention (CDC)—recently convened for a Harvard University panel to discuss efforts to expand veteran access to psychedelic-assisted therapy.
The fentanyl crisis continues to rage across the United States. Families from Alaska to Maine have felt the impact of this crisis driven by a manufactured opioid shake them to their core. Unfortunately, this crisis has reached our service members. In the U.S. Army and Navy, our two largest branches, we’ve learned that fentanyl deaths are on the rise.